Sun Pharmaceutical Industries Limited
NSE: SUNPHARMA · Healthcare
₹1,922.00
+12.00 (+0.63%)
Last close · 30 Aug 2026, 11:56 am IST
- Open
- ₹1,906.50
- Day high
- ₹1,922.00
- Day low
- ₹1,896.20
- Volume
- 12.21 L
- Prev close
- ₹1,910.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 100Nifty 200Nifty 50Nifty 500Nifty HealthcareNifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 4,65,735 Cr
- Price
- 1,941.10
- P/E (TTM)
- 40.65
- P/E (Fwd)
- 30.20
- P/B
- 5.57
- EV/EBITDA
- 26.80
- EV/Revenue
- 7.48
- PEG
- 1.04
- Div Yield
- 0.82%
- 52W High
- 1,966.50
- 52W Low
- 1,548.00
- Beta
- 0.08
Profitability & income
- Revenue (TTM)
- 58,462 Cr
- Net Income (TTM)
- 11,479 Cr
- EBITDA
- 16,313 Cr
- Gross Margin
- 78.65%
- Op. Margin
- 19.23%
- Net Margin
- 19.64%
- ROE
- 14.72%
- ROA
- 8.47%
- EPS (TTM)
- 47.75
- EPS (Fwd)
- 64.28
Financial health
- Total Debt
- 4,627 Cr
- Total Cash
- 33,517 Cr
- Debt/Equity
- 5.52
- Current Ratio
- 2.82
- Quick Ratio
- 2.18
- Book Value
- 348.31
- Free Cash Flow
- 5,948 Cr
- Op. Cash Flow
- 12,419 Cr
Growth
- Revenue Growth
- 12.80%
- Earnings Growth
- 25.10%
- Earnings QoQ
- 26.20%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 14,560 Cr | 2,714 Cr | 4,413 Cr | 2,752 Cr | 11,759 Cr | — | 4,627 Cr | 83,570 Cr |
| 2025-12-31 | 15,469 Cr | 3,369 Cr | 5,038 Cr | 4,062 Cr | 12,524 Cr | — | — | — |
| 2025-06-30 | 13,786 Cr | 2,279 Cr | 3,948 Cr | 3,372 Cr | 10,971 Cr | — | — | — |
| 2025-03-31 | 12,816 Cr | 2,150 Cr | 3,967 Cr | 2,761 Cr | 10,178 Cr | — | 2,362 Cr | 72,218 Cr |
| 2024-12-31 | 13,437 Cr | 2,903 Cr | 4,158 Cr | 3,562 Cr | 10,696 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 58,220 Cr | 11,479 Cr | 18,396 Cr | 13,595 Cr | 45,047 Cr | 12,419 Cr | 4,627 Cr | 83,570 Cr |
| 2025-03-31 | 52,041 Cr | 10,929 Cr | 16,559 Cr | 12,581 Cr | 39,844 Cr | 14,072 Cr | 2,362 Cr | 72,218 Cr |
| 2024-03-31 | 47,758 Cr | 9,576 Cr | 13,883 Cr | 10,468 Cr | 35,689 Cr | 12,135 Cr | 3,274 Cr | 63,667 Cr |
| 2023-03-31 | 43,279 Cr | 8,474 Cr | 12,111 Cr | 9,277 Cr | 31,336 Cr | 4,959 Cr | 6,886 Cr | 55,995 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for SUNPHARMA?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in